Obesity-It Must Not Remain the Neglected Risk Factor in Cardiology

Canadian Journal of Cardiology

Volumn 31, Issue 2, 2015, Pages 105-108

  Poirier, Paul ^a   McCrindle, Brian W ^b,c   Leiter, Lawrence A ^d  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INFLAMMASOME;

ABDOMINAL OBESITY; AGE DISTRIBUTION; ALGORITHM; ANTHROPOMETRIC PARAMETERS; ARTHRITIS; ATHEROSCLEROSIS; BARIATRIC SURGERY; BEHAVIOR CHANGE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CALORIC RESTRICTION; CARDIAC IMAGING; CARDIOLOGY; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHILDHOOD OBESITY; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DEPRESSION; DEVELOPED COUNTRY; DIETARY COMPLIANCE; DRUG INDUSTRY; DYSLIPIDEMIA; EATING HABIT; EDITORIAL; END STAGE RENAL DISEASE; ENDOTHELIAL DYSFUNCTION; ETHNIC GROUP; FINANCIAL MANAGEMENT; FOOD PREFERENCE; GROUPS BY AGE; HEALTH BEHAVIOR; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL VALUE; OBESITY; OUTCOME ASSESSMENT; PATHOGENESIS; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PREVALENCE; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH PROBLEM; REMISSION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SMOKING CESSATION; SUDDEN CARDIAC DEATH; SUDDEN DEATH; SURVIVAL RATE; SYSTEMIC DISEASE; TOBACCO; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT GAIN; WEIGHT REDUCTION; ADULT; AGED; CARDIOVASCULAR DISEASES; COMPLICATION; FEMALE; HEALTH; MALE; MIDDLE AGED; MORBIDITY; TRENDS; YOUNG ADULT;

ADULT; AGED; CARDIOLOGY; CARDIOVASCULAR DISEASES; FEMALE; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; MORBIDITY; OBESITY; RISK FACTORS; YOUNG ADULT;

EID: 84924954199     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.12.017     Document Type: Editorial

References (32)

1. Eckel R.H., Krauss R.M. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998, 97:2099-2100.
2. Cornier M.A., Despres J.P., Davis N., et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011, 124:1996-2019.
3. Ng M., Fleming T., Robinson M., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384:766-781.
4. Statistics Canada. Overweight and obese adults (self-reported), 2013. Available at: . Accessed December 9, 2014. http://www.statcan.gc.ca/pub/82-625-x/2014001/article/14021-eng.htm.
5. Public Health Agency of Canada. Obesity in Canada, 2011. Available at: . Accessed December 9, 2014. http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/oic-oac/index-eng.php.
6. Arkinson J., Ji H., Fallah S., Perez J., Dawson H. CIHI survey: bariatric surgery in Canada. Healthc Q 2010, 13:14-17.
7. Colquitt J.L., Picot J., Loveman E., Clegg A.J. Surgery for obesity. Cochrane Database Syst Rev 2009, 2:CD003641.
8. Lau D.C., Douketis J.D., Morrison K.M., et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007, 176:S1-S13.
9. Sassi F. Obesity and the Economics of Prevention: Fit not fat. Available at: . Accessed December 9, 2014. http://www.oecd.org/els/health-systems/46044572.pdf.
10. Lim S.S., Vos T., Flaxman A.D., et al. Acomparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260.
11. Whitlock G., Lewington S., Sherliker P., et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096.
12. Grover S.A., Kaouache M., Rempel P., et al. Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study. Lancet Diabetes Endocrinol 2015, 3:114-122.
13. Leiter L.A., Fitchett D.H., Gilbert R.E., et al. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol 2011, 27:124-131. Cardiometabolic Risk Working Group: Executive Committee.
14. Campbell N., Duhaney T., Arango M., et al. Healthy food procurement policy: an important intervention to aid the reduction in chronic noncommunicable diseases. Can J Cardiol 2014, 30:1456-1459.
15. McCrindle B.W. Cardiovascular consequences of childhood obesity. Can J Cardiol 2015, 31:124-130.
16. Tamayo C., Manlhiot C., Patterson K., Lalani S., McCrindle B.W. Longitudinal evaluation of the prevalence of overweight/obesity in children with congenital heart disease. Can J Cardiol 2015, 31:117-123.
17. Valera B., Sohani Z., Rana A., Poirier P., Anand S.S. The ethnoepidemiology of obesity. Can J Cardiol 2015, 31:131-141.
18. Nazare J.A., Smith J., Borel A.L., et al. Changes in both global diet quality and physical activity level synergistically reduce visceral adiposity in men with features of metabolic syndrome. JNutr 2013, 143:1074-1083.
19. Drolet B., Simard C., Poirier P. Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs. Am J Cardiovasc Drugs 2007, 7:273-288.
20. Pucci A., Finer N. New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol 2015, 31:142-152.
21. Piché M.-È., Auclair A., Harvey J., Marceau S., Poirier P. How to choose and use bariatric surgery in 2015. Can J Cardiol 2015, 31:153-166.
22. Sankaralingam S., Kim R.B., Padwal R.S. The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control. Can J Cardiol 2015, 31:167-176.
23. Lovren F., Teoh H., Verma S. Obesity and atherosclerosis: mechanistic insights. Can J Cardiol 2015, 31:177-183.
24. Garcia-Labbé D., Ruka E., Bertrand O.F., Voisine P., Costerousse P., Poirier P. Obesity and coronary artery disease: evaluation and treatment. Can J Cardiol 2015, 31:184-194.
25. Lim S.P., Arasaratnam P., Chow B.J., Beanlands R.S., Hessian R.C. Obesity and the challenges of noninvasive imaging for the detection of coronary artery disease. Can J Cardiol 2015, 31:223-226.
26. Gupta P.P., Fonarow G.C., Horwich T.B. Obesity and the obesity paradox in heart failure. Can J Cardiol 2015, 31:195-202.
27. Pathak R.K., Mahajan R., Lau D.H., Sanders P. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol 2015, 31:203-210.
28. Lu Y., Hajifathalian K., Ezzati M., et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014, 383:970-983.
29. Kramer C.K. Weight loss is a useful therapeutic objective. Can J Cardiol 2015, 31:211-215.
30. Després J.P. Obesity and cardiovascular disease: weight loss is not the only target. Can J Cardiol 2015, 31:216-222.
31. Teoh H., Despres J.P., Dufour R., et al. Identification and management of patients at elevated cardiometabolic risk in Canadian primary care: how well are we doing?. Can J Cardiol 2013, 29:960-968.
32. Teoh H., Despres J.P., Dufour R., et al. Acomparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care. Diabetes Obes Metab 2013, 15:1093-1100.